Sildenafil: a 4-year update in the treatment of 20 million erectile dysfunction patients.

Current urology reports

Volumn 4, Issue 6, 2003, Pages 488-496

  Carson 3rd , Culley C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CGMP BINDING, CGMP SPECIFIC 3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CGMP-BINDING, CGMP-SPECIFIC 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CYCLIC GMP PHOSPHODIESTERASE; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; PIPERAZINE DERIVATIVE; SILDENAFIL;

DRUG INTERACTION; DRUG SCREENING; HEART DISEASE; HUMAN; IMPOTENCE; MALE; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ANTIHYPERTENSIVE AGENTS; DRUG EVALUATION; DRUG INTERACTIONS; HEART DISEASES; HUMANS; IMPOTENCE; MALE; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; PIPERAZINES; RISK FACTORS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 1542546284     PISSN: 15272737     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11934-003-0031-1     Document Type: Review

References (52)